- Investing Ideas
- Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swedish Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
7
Mid-Large Cap Stocks
7 companies
BioGaia
Market Cap: SEK 11.4b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 113.00
7D
1.3%
1Y
19.6%
Vitrolife
Market Cap: SEK 12.3b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 90.95
7D
1.1%
1Y
-33.3%
AddLife
Market Cap: SEK 19.6b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 160.90
7D
-2.3%
1Y
-2.5%
Camurus
Market Cap: SEK 36.7b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 617.50
7D
1.7%
1Y
-4.8%
Bonesupport Holding
Market Cap: SEK 14.7b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 223.60
7D
0%
1Y
-20.8%
BioArctic
Market Cap: SEK 28.4b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 319.60
7D
1.7%
1Y
34.2%
Swedish Orphan Biovitrum
Market Cap: SEK 152.9b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 440.40
7D
-2.8%
1Y
60.8%